Evidence map›Paper›PMID 25472841›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylation.

Stefanie Renee DeVito, Emilio Ortiz-Riaño, Luis Martínez-Sobrido, Joshua Munger

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Human cytomegalovirus promotesJournal of virology · 2025
    Article
  11. Review
  12. Human cytomegalovirus promotesbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Article
  15. Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stefanie Renee DeVitoDepartments of Biochemistry and Biophysics and.
Emilio Ortiz-RiañoMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642.
Luis Martínez-SobridoMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642.
Joshua MungerDepartments of Biochemistry and Biophysics and josh.munger@rochester.edu.
University of Rochester Medical Center · US

Funding

Training in Cellular, Biochemical and Molecular SciencesT32GM068411 · NIGMS · UNIVERSITY OF ROCHESTER · PI MAQUAT, LYNNE E · 2005 to 2019
$3.9M
Training in HIV Replication and PathogenesisT32AI049815 · NIAID · UNIVERSITY OF ROCHESTER · PI WEDEKIND, JOSEPH E · 2001 to 2020
$3.5M
Metabolic regulatory mechanisms essential for Human Cytomegalovirus replicationR01AI081773 · NIAID · UNIVERSITY OF ROCHESTER · PI MUNGER, JOSHUA C · 2010 to 2014
$1.7M
Anti-interferon Activity of the Arenavirus NucleoproteinR01AI077719 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C., MARTINEZ-SOBRIDO, LUIS · 2009 to 2012
$1.6M
Metabolic regulatory mechanisms essential for Human Cytomegalovirus replicationR56AI081773 · NIAID · UNIVERSITY OF ROCHESTER · PI MUNGER, JOSHUA C · 2015 to 2015
$384k
Single-cycle Infectious Candid#1 to Study Hemorrhagic Fever New World ArenavirusR03AI099681 · NIAID · UNIVERSITY OF ROCHESTER · PI MARTINEZ-SOBRIDO, LUIS · 2012 to 2013
$154k
NIAID NIH HHS AI049815-13NIAID NIH HHS HHSN266200700008CNIAID NIH HHS HHSN272201000055CNIAID NIH HHS R01 AI077719NIAID NIH HHS R01 AI081773NIAID NIH HHS R01AI081773NIAID NIH HHS R03 AI099681NIAID NIH HHS R03AI099681-01A1NIAID NIH HHS R56 AI081773NIAID NIH HHS T32 AI049815NIGMS NIH HHS GM068411NIGMS NIH HHS T32 GM068411PHS HHS HHSN266200700008CPHS HHS HHSN272201000055C
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) induces numerous changes to the host metabolic network that are critical for high-titer viral replication. We find that HCMV infection substantially induces de novo pyrimidine biosynthetic flux. This activation is important for HCMV replication because inhibition of pyrimidine biosynthetic enzymes substantially decreases the production of infectious virus, which can be rescued through medium supplementation with pyrimidine biosynthetic intermediates. Metabolomic analysis revealed that pyrimidine biosynthetic inhibition considerably reduces the levels of various UDP-sugar metabolites in HCMV-infected, but not mock-infected, cells. Further, UDP-sugar biosynthesis, which provides the sugar substrates required for glycosylation reactions, was found to be induced during HCMV infection. Pyrimidine biosynthetic inhibition also attenuated the glycosylation of the envelope glycoprotein B (gB). Both glycosylation of gB and viral growth were restored by medium supplementation with either UDP-sugar metabolites or pyrimidine precursors. These results indicate that HCMV drives de novo-synthesized pyrimidines to UDP-sugar biosynthesis to support virion protein glycosylation. The importance of this link between pyrimidine biosynthesis and UDP-sugars appears to be partially shared among diverse virus families, because UDP-sugar metabolites rescued the growth attenuation associated with pyrimidine biosynthetic inhibition during influenza A and vesicular stomatitis virus infection, but not murine hepatitis virus infection. In total, our results indicate that viruses can specifically modulate pyrimidine metabolic flux to provide the glycosyl subunits required for protein glycosylation and production of high titers of infectious progeny.

Indexed as

Analysis of VarianceChromatography, LiquidCytomegalovirusDNA PrimersGlycosylationHumansMetabolic Flux AnalysisPyrimidinesReal-Time Polymerase Chain ReactionRNA InterferenceTandem Mass SpectrometryUridine Diphosphate SugarsViral Envelope ProteinsVirus ReplicationDNA PrimerspyrimidinePyrimidinesUridine Diphosphate SugarsViral Envelope ProteinscytomegalovirusglycosylationmetabolismpyrimidineUDP–sugar

Identifiers

PMID25472841
PMCPMC4273352
OpenAlexW1976447515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.